Abstract:Human milk oligosaccharides (HMOs) have been proven to be beneficial to infants' intestinal health and immune systems. 2′-Fucosyllactose (2′-FL) is the most abundant and thoroughly studied HMO and has been approved to be an additive of infant formula. How to construct efficient and safe microbial cell factories for the production of 2′-FL attracts increasing attention. In this work, we engineered the Bacillus subtilis as an efficient 2′-FL producer by engineering the substrate transport and cofactor guanosine 5′-triphosphate (GTP) regeneration systems. First, we constructed a synthesis pathway for the 2′-FL precursor guanosine 5′-diphosphate-l-fucose (GDP-l-fucose) by introducing the salvage pathway gene fkp from Bacteriodes fragilis and improved the fucose importation by overexpressing the transporters. Then, the complete synthesis pathway of 2′-FL was constructed by introducing the heterologous fucosyltransferases from different sources, and it was found that the gene from Helicobacter pylori was the best one for 2′-FL synthesis. We also improved the substrate lactose importation by introducing heterologous lactose permeases and eliminated endogenous β-galactosidase (yesZ) to block the lactose degradation. Next, the production of 2′-FL and GDP-l-fucose was improved by fine-tuning the expression of cofactor guanosine 5′-triphosphate regeneration module genes gmd, ndk, guaA, guaC, ykfN, deoD, and xpt. Finally, a 3 L fed-batch fermentation was performed, and the highest 2′-FL titer reached 5.01 g/L with a yield up to 0.85 mol/mol fucose. We optimized the synthesis modules of 2′-FL in B. subtilis, and this provides a good starting point for metabolic engineering to further improve 2′-FL production in the future.

Substrate and process engineering for biocatalytic synthesis and facile purification of human milk oligosaccharides (HMOs).

Enzymatic Synthesis of Oligosaccharides and Conversion to Glycolipids

Automated chemoenzymatic modular synthesis of human milk oligosaccharides on a digital microfluidic platform

Synthesis of Human Milk Oligosaccharides: Protein Engineering Strategies for Improved Enzymatic Transglycosylation

Cation Exchange Assisted Binding-Elution Strategy for Enzymatic Synthesis of Human Milk Oligosaccharides (Hmos).

Versatile Strategy for the Chemoenzymatic Synthesis of Branched Human Milk Oligosaccharides Containing the Lacto‐N‐biose Motif

Engineered Glycosidases for the Synthesis of Analogs of Human Milk Oligosaccharides

Microbial production of human milk oligosaccharide lactodifucotetraose

Recent Advances in the Microbial Production of Human Milk Oligosaccharides

Production of human milk oligosaccharides by enzymatic and whole-cell microbial biotransformations

Recent advances and challenges in microbial production of human milk oligosaccharides

Multi-Enzymatic Cascade One-Pot Biosynthesis of 3′-Sialyllactose Using Engineered Escherichia coli

An Overview of Sugar Nucleotide-Dependent Glycosyltransferases for Human Milk Oligosaccharide Synthesis

Co-immobilization of a bi-enzymatic cascade into hierarchically porous MIL-53 for efficient 6'-sialyllactose production

Modular bioengineering of whole-cell catalysis for sialo-oligosaccharide production: coordinated co-expression of CMP-sialic acid synthetase and sialyltransferase

Sulfo-Fluorous Tagging Strategy for Site-Selective Enzymatic Glycosylation of para -Human Milk Oligosaccharides

[Multicellular coupling fermentation for 3'-sialyllactose conversion using N-acetyl-glucosamine and lactose]

Engineering the Substrate Transport and Cofactor Regeneration Systems for Enhancing 2′-Fucosyllactose Synthesis in Bacillus subtilis

Liquid-Phase and Ultrahigh-Frequency-Acoustofluidics-Based Solid-Phase Synthesis of Biotin-Tagged 6′/3′-Sialyl-N-Acetylglucosamine by Sequential One-Pot Multienzyme System

Sequential One-Pot Multienzyme (OPME) Synthesis of Lacto-N-neotetraose and Its Sialyl and Fucosyl Derivatives

Efficient production of 2′-fucosyllactose from fructose through metabolically engineered recombinant Escherichia coli